Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study

OBJECTIVE: In a number of controlled clinical trials and naturalistic studies, aripiprazole once monthly (AOM) has been found to be effective and safe as acute and maintenance treatment options for schizophrenia. However, such clinical data have been presented in selected patient population (i.e., a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pae, Chi-Un, Han, Changsu, Bahk, Won-Myong, Lee, Soo-Jung, Patkar, Ashwin A., Masand, Prakash S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077057/
https://www.ncbi.nlm.nih.gov/pubmed/33888652
http://dx.doi.org/10.9758/cpn.2021.19.2.233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077057/
https://www.ncbi.nlm.nih.gov/pubmed/33888652
http://dx.doi.org/10.9758/cpn.2021.19.2.233

Ejemplares similares